|
|
|
|
| LEADER |
03048nam a22005655i 4500 |
| 001 |
978-3-642-29423-5 |
| 003 |
DE-He213 |
| 005 |
20151105131006.0 |
| 007 |
cr nn 008mamaa |
| 008 |
120823s2012 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783642294235
|9 978-3-642-29423-5
|
| 024 |
7 |
|
|a 10.1007/978-3-642-29423-5
|2 doi
|
| 040 |
|
|
|d GrThAP
|
| 050 |
|
4 |
|a RM1-950
|
| 072 |
|
7 |
|a MMG
|2 bicssc
|
| 072 |
|
7 |
|a MED071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615
|2 23
|
| 245 |
1 |
0 |
|a Antiplatelet Agents
|h [electronic resource] /
|c edited by Paolo Gresele, Gustav V. R Born, Carlo Patrono, Clive P. Page.
|
| 264 |
|
1 |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 2012.
|
| 300 |
|
|
|a XII, 616 p.
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a text file
|b PDF
|2 rda
|
| 490 |
1 |
|
|a Handbook of Experimental Pharmacology,
|x 0171-2004 ;
|v 210
|
| 505 |
0 |
|
|a Foreword -- Preface -- Part 1. Pathophysiology -- Part 2. Pharmacology -- Part 3. Therapy.
|
| 520 |
|
|
|a Antiplatelet therapy is the cornerstone of treatment of ischemic cardiovascular disease and over the last few years spectacular advancements in this field have been recorded. This is the first comprehensive handbook entirely dedicated to all the aspects of antiplatelet therapy. The book is divided into three main sections, pathophysiology, pharmacology and therapy, for a total of 23 chapters. A large group of leading experts from different European countries and from the USA, both from academia and industry, have contributed to the book. Besides a detailed overview on the pharmacology and clinical applications of all the currently used or of the novel antiplatelet agents, innovative approaches (e.g. intracellular signalling as an antiplatelet target, small RNAs as platelet therapeutics, etc.) or unconventional aspects (e.g. pharmacologic modulation of the inflammatory action of platelets are also treated. The book is oriented to both basic investigators and to clinicians involved with research on platelet inhibition or with the clinical use of antiplatelet therapies.
|
| 650 |
|
0 |
|a Medicine.
|
| 650 |
|
0 |
|a Molecular biology.
|
| 650 |
|
0 |
|a Pharmacology.
|
| 650 |
|
0 |
|a Internal medicine.
|
| 650 |
|
0 |
|a Cardiology.
|
| 650 |
|
0 |
|a Neurology.
|
| 650 |
1 |
4 |
|a Biomedicine.
|
| 650 |
2 |
4 |
|a Pharmacology/Toxicology.
|
| 650 |
2 |
4 |
|a Cardiology.
|
| 650 |
2 |
4 |
|a Internal Medicine.
|
| 650 |
2 |
4 |
|a Neurology.
|
| 650 |
2 |
4 |
|a Molecular Medicine.
|
| 700 |
1 |
|
|a Gresele, Paolo.
|e editor.
|
| 700 |
1 |
|
|a Born, Gustav V. R.
|e editor.
|
| 700 |
1 |
|
|a Patrono, Carlo.
|e editor.
|
| 700 |
1 |
|
|a Page, Clive P.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 776 |
0 |
8 |
|i Printed edition:
|z 9783642294228
|
| 830 |
|
0 |
|a Handbook of Experimental Pharmacology,
|x 0171-2004 ;
|v 210
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-3-642-29423-5
|z Full Text via HEAL-Link
|
| 912 |
|
|
|a ZDB-2-SBL
|
| 950 |
|
|
|a Biomedical and Life Sciences (Springer-11642)
|
